GlassScriptPhysician profile
Michael P Swords
NPI 1942275490
$188,642.65
in general payments reported to CMS, 2019-2025
26 companies · $3,300 in 2025
The $3,300 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $23K · 2021: $65K · 2022: $18K · 2023: $48K · 2024: $9,030 · 2025: $3,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Travel and Lodging: $15K · Honoraria: $7,903 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,672 · Food and Beverage: $1,785 · Royalty Or License: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,087.09 |
| Travel and Lodging | $15,306.65 |
| Honoraria | $7,902.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,672.00 |
| Food and Beverage | $1,784.95 |
| Royalty Or License | $1,290.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $85,431.63 | 2019-2025 | Lcp, Va-Lcp, Na |
| Synthes Gmbh | $65,646.25 | 2019-2023 | |
| Osteocentric Technologies, INC. | $11,486.92 | 2019-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Synthes USA Products LLC | $7,981.33 | 2020-2024 | Na, Tomofix |
| Depuy Synthes Sales INC. | $6,814.29 | 2020-2023 | Na, Orthovisc, Monovisc |
| Distalmotion US | $6,517.64 | 2024 | Dexter L6 Robot |
| Medwest Associates | $786.80 | 2021 | |
| Stryker Corporation | $756.39 | 2020-2025 | Augment Injectable, Inbone, Mako |
| Intuitive Surgical, INC. | $726.54 | 2025 | |
| Arthrex, INC. | $662.00 | 2021 | |
| Paragon 28, INC. | $637.08 | 2019-2023 | Apex 3d |
| Smith+Nephew, INC. | $368.12 | 2022-2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Abbott Laboratories | $343.84 | 2022 | |
| Biocomposites INC | $120.62 | 2024 | |
| Davol INC. | $80.93 | 2024 | Arista Ah Flexitip |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $63.31 | 2019-2020 | |
| Bioventus LLC | $35.06 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Ferring Pharmaceuticals INC. | $33.09 | 2022-2025 | Euflexxa |
| Orthofix Medical, INC. | $32.38 | 2024 | Cervical-Stim |
| Radius Health, INC. | $27.52 | 2019-2020 | |
| Abbvie INC. | $23.22 | 2023 | Dalvance |
| Ethicon US, LLC | $19.83 | 2019 | |
| Ermi LLC | $19.20 | 2019 | |
| Solventum Corporation | $15.57 | 2024 | Prevena |
| Sanofi-Aventis U.S. LLC | $13.09 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Swords listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.